作者
Balázs Nemes, Roland Fedor, Zsolt Kanyári, Lajos Lőcsey, Ferenc Juhász, Dávid Ágoston Kovács, Gergely Zádori, Ferenc Győry, L Zsom, T Szabó, L Illésy, M Szabó-Pap, Z Kincses, L Szabó, L Damjanovich, J Balla, L Asztalos
发表日期
2016/6/1
期刊
Orvosi Hetilap
卷号
157
期号
24
页码范围
925-937
简介
Method
Comparison between Period A (from January 1, 2008 to August 31, 2013) and Period B (from September 1, 2013 to October 22, 2015).
Results
The proportion of living transplants rose from 3.5% to 9.1%. During period B over 25% of utilized donors were over 60 years of age. Recipients with body mass index above 30 kg/m (2) increased from 12% to 31%. Prevalence of diabetes among recipients rose twofold. Uretero-neocystostomy was used during period A (99%) while in period B end to side uretero-ureteral anastomosis has also gained popularity (68%). In 2013 the authors introduced routine use of induction treatment. Acute rejection rate decreased from 34% to 8%. The rate of surgical complications did not change. Acute bacterial infections decreased from 41% to 33%. Cumulative renal allograft 1, 3 and 5 year survival rates were 86.6%, 85% and 82.7% in group A vs. projected rates 88%, 84% and 84% in group B, respectively.
Conclusions
Despite the growing proportion of expanded criteria donors, the authors were able to maintain a low incidence of delayed graft function and a favorable graft survival. Since 2013 the authors introduced treatments for acute humoral rejection according to international standards.
引用总数
20172018201920202021202220233612421